The purpose of this study is to investigate treatment options for patients with multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. This study aims to understand if combining an investigational medication with another treatment can be beneficial for patients.
Participants in this study will undergo various procedures to monitor the effects of the investigational medication. These procedures will help researchers gather important information about the treatment's impact on multiple myeloma.
- Who can participate: Eligible participants are adults diagnosed with multiple myeloma. Specific age criteria and other eligibility factors will be determined by the study team.
- Study details: Participants will receive the investigational medication along with another treatment. There is no mention of a placebo in this study.
